Arbutus Biopharma's total assets for Q3 2025 were $97.71M, a decrease of -5.38% from the previous quarter. ABUS total liabilities were $20.31M for the fiscal quarter, a 0.10% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.